Cadila Pharmaceuticals
Drug Stores & Pharmacies · India · 8,000 Employees
Who is Cadila Pharmaceuticals
Founded in 1951, Cadila Pharmaceuticals is a privately held pharmaceutical company in India. The company's integrated operations cover the entire gamut from manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products, and pharmaceutical Machinery.Read More
Headquarters:
Survey No. 1389, Trasad Rd, Dholka, Dholka, Gujarat, 382225, India
Phone Number:
+91 2714 220 315
Revenue:
$1 Billion
Cadila Pharmaceuticals's Social Media
Popular Searches:
Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals
Cadila Healthcare Limited
Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd
Top Competitors of Cadila Pharmaceuticals
Cadila Pharmaceuticals's Org Chart
Cadila Pharmaceuticals Email Formats
Cadila Pharmaceuticals uses at least 5 email formats with first.last (ex. John.Smith@cadilapharma.co.in) being used 86% of the time
Get Verified Emails
| Cadila Pharmaceuticals Email Formats | Percentage | |
|---|---|---|
| first.last | John.Smith@cadilapharma.co.in | 86% |
| first + last | JohnSmith@cadilapharma.co.in | |
| first_last | John_Smith@cadilapharma.co.in | |
| first | John@cadilapharma.co.in | |
| last | Smith@cadilapharma.co.in | |
Cadila Pharmaceuticals Company Metrics
Revenue
| Quarter | Revenue |
|---|---|
'21 - Q1 | 1362172000 |
'21 - Q2 | 1362172000 |
Cadila Pharmaceuticals's Tech Stack
Cadila Pharmaceuticals News & Media
Cadila Healthcare's US arm receives FDA nod to market Pimavanserin capsule
Cadila Healthcare on Friday said its US arm Zydus Pharmaceuticals (USA) Inc has received tentative approval from the US health regulator to market generic Pimavanserin capsules, indicated for treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The approval by the US Food & Drug Administration for the generic Pimavanserin capsules is for the strength of 34 mg, Cadila Healthcare said in a regulatory filing. "The drug will be manufactured at the group's formulat
Dec 31, 2021USD 444.54 mn growth for Dravet Syndrome Treatment Market by 2025 |Evolving Opportunities with Cadila Healthcare Ltd. & Epygenix Therapeutics Inc.|17000+ Technavio Reports
NEW YORK, Nov. 25, 2021 /PRNewswire/ -- The "Dravet Syndrome Treatment Market - Competitive Analysis, Trends, Drivers, Challenges, and Five Force Analysis" report has been added to Technavio's offering. The dravet syndrome treatment market size is expected to increase by USD 444.54...Nov 26, 2021
Cadila Healthcare Q2 PAT up by 6% YoY to Rs 597 cr, revenue up 3%
The company's EBIDTA margin for the quarter was 22.7 per cent, up by 50 basis pointsOct 29, 2021Subscribe to "Cadila Pharmaceuticals" News
Frequently Asked Questions regarding Cadila Pharmaceuticals
Where are Cadila Pharmaceuticals’s headquarters?
Cadila Pharmaceuticals’s headquarters are in Survey No. 1389, Trasad Rd, Dholka, Dholka, Gujarat, 382225, India
What is Cadila Pharmaceuticals’s phone number?
Cadila Pharmaceuticals’s phone number is +91 2714 220 315
What is Cadila Pharmaceuticals’s official website?
Cadila Pharmaceuticals’s official website is www.cadilapharma.com
What is Cadila Pharmaceuticals’s Revenue?
Cadila Pharmaceuticals’s revenue is $1 Billion
What is Cadila Pharmaceuticals’s SIC code?
Cadila Pharmaceuticals’s SIC: 28,283
What is Cadila Pharmaceuticals’s NAICS code?
Cadila Pharmaceuticals’s NAICS: 32541,325
How many employees are working in Cadila Pharmaceuticals?
Cadila Pharmaceuticals has 8,000 employees
What is Cadila Pharmaceuticals’s industry?
Cadila Pharmaceuticals is in the industry of: Drug Stores & Pharmacies, Retail
Who are Cadila Pharmaceuticals’s main competitors?
Cadila Pharmaceuticals's main competitors are: Aurobindo Pharma, Polpharma, Dr. Reddy's Laboratories, Wockhardt
What is Cadila Pharmaceuticals's tech stack?
The technologies that are used by Cadila Pharmaceuticals are: Achievers, Cloudflare CDN, Lightspeed Web Store, Microsoft Teams
Test Drive ZoomInfo's Directories
Browse Directories
